D
Nektar Therapeutics NKTR
$0.8968 $0.08149.98%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 24.12M 23.49M 21.64M 23.89M 24.14M
Total Other Revenue -- -- -- -- --
Total Revenue 24.12M 23.49M 21.64M 23.89M 24.14M
Cost of Revenue 4.44M 9.74M 8.53M 7.28M 12.43M
Gross Profit 19.69M 13.75M 13.11M 16.60M 11.71M
SG&A Expenses 18.96M 20.51M 20.15M 17.32M 21.15M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 58.42M 59.97M 56.09M 54.55M 57.65M
Operating Income -34.30M -36.49M -34.45M -30.66M -33.50M
Income Before Tax -37.05M -52.32M -36.84M -42.11M -45.90M
Income Tax Expenses 9.00K 46.00K -35.00K -29.00K -61.00K
Earnings from Continuing Operations -37.06M -52.36M -36.80M -42.08M -45.84M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -37.06M -52.36M -36.80M -42.08M -45.84M
EBIT -34.30M -36.49M -34.45M -30.66M -33.50M
EBITDA -33.31M -35.03M -32.85M -29.01M -31.81M
EPS Basic -0.18 -0.25 -0.19 -0.22 -0.24
Normalized Basic EPS -0.11 -0.12 -0.12 -0.11 -0.11
EPS Diluted -0.18 -0.25 -0.19 -0.22 -0.24
Normalized Diluted EPS -0.11 -0.12 -0.12 -0.11 -0.11
Average Basic Shares Outstanding 209.25M 208.83M 194.75M 191.04M 190.41M
Average Diluted Shares Outstanding 209.25M 208.83M 194.75M 191.04M 190.41M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings